Trials / Conditions / Klippel Trenaunay Syndrome

Klippel Trenaunay Syndrome

8 registered clinical trials studyying Klippel Trenaunay Syndrome — 4 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	A Study to Investigate Efficacy and Safety of KP-001 Compared With Placebo in Patients Aged ≥2 Years With Comm NCT07285005	Kaken Pharmaceutical	Phase 3
Recruiting	A Phase 2 Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, in Adults and Children With PIK3CA Related Over NCT06789913	Relay Therapeutics, Inc.	Phase 2
Active Not Recruiting	Safety of the Sonablate HIFU System for the Ablation of Incompetent Veins of the Periphery NCT06642051	Sonablate	N/A
Completed	National Evaluation of Patients With PIK3CA-Related Overgrowth Spectrum (PROS) NCT05563831	Institut National de la Santé Et de la Recherche Médicale, France	—
Completed	Vascular Anomaly Pathology and Genomics Biopsy Study NCT04836884	Mayo Clinic	N/A
Recruiting	Identification of Biomarkers for Patients with Vascular Anomalies NCT03001180	Children's Hospital Medical Center, Cincinnati	—
Recruiting	Lymphatic Anomalies Registry for the Assessment of Outcome Data NCT02399527	Boston Children's Hospital	—
Completed	French National Cohort of Children With Port Wine Stain NCT01364857	University Hospital, Tours	N/A